Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |